{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T09:24:48Z","timestamp":1783329888555,"version":"3.54.6"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T00:00:00Z","timestamp":1783296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T00:00:00Z","timestamp":1783296000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Abdom Radiol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Accurate staging of renal cell carcinoma (RCC) is critical because small differences in imaging interpretation can alter operative planning, systemic treatment decisions, and prognosis. This educational review highlights the practical role of multimodality imaging in RCC staging, with emphasis on common interpretive pitfalls and reporting strategies that improve clinical decision-making. Contrast-enhanced CT and MRI remain the foundation of local staging, enabling assessment of tumour size, renal sinus and perinephric extension, venous tumour thrombus, and spread beyond the perinephric fascia. However, several features are prone to overcall or undercall, particularly renal sinus invasion, perinephric invasion, inferior vena cava wall involvement, and adjacent organ invasion, with direct implications for management. Regional and distant staging are likewise imperfect. Nodal assessment remains limited by the overlap between reactive enlargement and metastatic disease, while indeterminate pulmonary nodules, marrow-based bone metastases, and atypical metastatic sites may all complicate interpretation. Selected technical considerations, including the potential value of arterial phase imaging in suspected clear cell RCC and the problem-solving role of MRI in equivocal local staging, may help reduce understaging. The role of PET and emerging targeted tracers remains selective rather than routine. Throughout, emphasis is placed on management-relevant imaging findings, modality-specific strengths and weaknesses, and practical pearls derived from experience. A structured reporting approach is also proposed to improve completeness, consistency, and communication with the multidisciplinary team.<\/jats:p>","DOI":"10.1007\/s00261-026-05660-5","type":"journal-article","created":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T07:27:26Z","timestamp":1783322846000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Multimodality staging of renal cell carcinoma\u2014pearls &amp; pitfalls"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3612-844X","authenticated-orcid":false,"given":"Samuel J.","family":"Withey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milagros","family":"Otero-Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Aymerich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandra","family":"Baiz\u00e1n-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Carnelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Hesketh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iztok","family":"Caglic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,6]]},"reference":[{"key":"5660_CR1","unstructured":"National Cancer Institute. Cancer Stat Facts: Kidney and Renal Pelvis Cancer [Internet]. Bethesda (MD): National Cancer Institute; [cited 2026 March 17]. Available from: https:\/\/seer.cancer.gov\/statfacts\/html\/kidrp.html"},{"key":"5660_CR2","unstructured":"American Joint Commission on Cancer. AJCC Cancer Staging Manual. 8th Edition ed. Amin MB, Edge, S., Greene, F., Byrd, D.R., Brookland, R.K., Washington, M.K., Gershenwald, J.E., Compton, C.C., Hess, K.R., Sullivan, D.C., Jessup, J.M., Brierley, J.D., Gaspar, L.E., Schilsky, R.L., Balch, C.M., editor: Springer International Publishing; 2017."},{"issue":"45","key":"5660_CR3","doi-asserted-by":"publisher","first-page":"e293","DOI":"10.3346\/jkms.2024.39.e293","volume":"39","author":"CH Lee","year":"2024","unstructured":"Lee CH, Kang M, Kwak C, Ko YH, Kim JK, Park JY, et al. Sites of Metastasis and Survival in Metastatic Renal Cell Carcinoma: Results From the Korean Renal Cancer Study Group Database. J Korean Med Sci. 2024;39(45):e293.","journal-title":"J Korean Med Sci"},{"issue":"4","key":"5660_CR4","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1093\/annonc\/mdr362","volume":"23","author":"M Bianchi","year":"2012","unstructured":"Bianchi M, Sun M, Jeldres C, Shariat SF, Trinh QD, Briganti A, et al. Distribution of metastatic sites in renal cell carcinoma: a population-based analysis. Annals of oncology: official journal of the European Society for Medical Oncology. 2012;23(4):973\u201380.","journal-title":"Annals of oncology: official journal of the European Society for Medical Oncology"},{"issue":"11","key":"5660_CR5","doi-asserted-by":"publisher","first-page":"5431","DOI":"10.1002\/cam4.1790","volume":"7","author":"N Shao","year":"2018","unstructured":"Shao N, Wang HK, Zhu Y, Ye DW. Modification of American Joint Committee on cancer prognostic groups for renal cell carcinoma. Cancer Med. 2018;7(11):5431\u20138.","journal-title":"Cancer Med"},{"issue":"1","key":"5660_CR6","doi-asserted-by":"publisher","first-page":"e2021869","DOI":"10.1001\/jamanetworkopen.2020.21869","volume":"4","author":"S Dudani","year":"2021","unstructured":"Dudani S, de Velasco G, Wells JC, Gan CL, Donskov F, Porta C, et al. Evaluation of Clear Cell, Papillary, and Chromophobe Renal Cell Carcinoma Metastasis Sites and Association With Survival. JAMA Netw Open. 2021;4(1):e2021869.","journal-title":"JAMA Netw Open"},{"issue":"2","key":"5660_CR7","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1097\/JU.0000000000001911","volume":"206","author":"SC Campbell","year":"2021","unstructured":"Campbell SC, Clark PE, Chang SS, Karam JA, Souter L, Uzzo RG. Renal Mass and Localized Renal Cancer: Evaluation, Management, and Follow-Up: AUA Guideline: Part I. J Urol. 2021;206(2):199\u2013208.","journal-title":"J Urol"},{"issue":"6","key":"5660_CR8","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/j.eururo.2025.02.020","volume":"87","author":"A Bex","year":"2025","unstructured":"Bex A, Ghanem YA, Albiges L, Bonn S, Campi R, Capitanio U, et al. European Association of Urology Guidelines on Renal Cell Carcinoma: The 2025 Update. Eur Urol. 2025;87(6):683\u201396.","journal-title":"Eur Urol"},{"issue":"3","key":"5660_CR9","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.ucl.2020.04.005","volume":"47","author":"SVL Vig","year":"2020","unstructured":"Vig SVL, Zan E, Kang SK. Imaging for Metastatic Renal Cell Carcinoma. Urol Clin North Am. 2020;47(3):281\u201391.","journal-title":"Urol Clin North Am"},{"issue":"4","key":"5660_CR10","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1111\/bju.13670","volume":"120","author":"A Larcher","year":"2017","unstructured":"Larcher A, Dell\u2019Oglio P, Fossati N, Nini A, Muttin F, Suardi N, et al. When to perform preoperative chest computed tomography for renal cancer staging. BJU Int. 2017;120(4):490\u20136.","journal-title":"BJU Int"},{"issue":"1","key":"5660_CR11","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.juro.2009.02.128","volume":"182","author":"RH Thompson","year":"2009","unstructured":"Thompson RH, Hill JR, Babayev Y, Cronin A, Kaag M, Kundu S, et al. Metastatic renal cell carcinoma risk according to tumor size. J Urol. 2009;182(1):41\u20135.","journal-title":"J Urol"},{"issue":"6","key":"5660_CR12","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1016\/j.urology.2010.12.077","volume":"77","author":"RJ Zagoria","year":"2011","unstructured":"Zagoria RJ, Pettus JA, Rogers M, Werle DM, Childs D, Leyendecker JR. Long-term outcomes after percutaneous radiofrequency ablation for renal cell carcinoma. Urology. 2011;77(6):1393\u20137.","journal-title":"Urology"},{"issue":"3","key":"5660_CR13","doi-asserted-by":"publisher","first-page":"541","DOI":"10.2214\/AJR.21.25493","volume":"217","author":"AA Elkassem","year":"2021","unstructured":"Elkassem AA, Allen BC, Sharbidre KG, Rais-Bahrami S, Smith AD. Update on the Role of Imaging in Clinical Staging and Restaging of Renal Cell Carcinoma Based on the AJCC 8th Edition, From the AJR Special Series on Cancer Staging. AJR Am J Roentgenol. 2021;217(3):541\u201355.","journal-title":"AJR Am J Roentgenol"},{"issue":"8","key":"5660_CR14","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.3348\/kjr.2020.0984","volume":"22","author":"JH Kim","year":"2021","unstructured":"Kim JH, Park KJ, Kim MH, Kim JK. Preoperative Assessment of Renal Sinus Invasion by Renal Cell Carcinoma according to Tumor Complexity and Imaging Features in Patients Undergoing Radical Nephrectomy. Korean J Radiol. 2021;22(8):1323\u201331.","journal-title":"Korean J Radiol"},{"issue":"3","key":"5660_CR15","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1016\/j.juro.2009.05.035","volume":"182","author":"A Kutikov","year":"2009","unstructured":"Kutikov A, Uzzo RG. The R.E.N.A.L. nephrometry score: a comprehensive standardized system for quantitating renal tumor size, location and depth. J Urol. 2009;182(3):844\u201353.","journal-title":"J Urol"},{"issue":"4","key":"5660_CR16","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1111\/his.13672","volume":"73","author":"K Taneja","year":"2018","unstructured":"Taneja K, Arora S, Rogers CG, Gupta NS, Williamson SR. Pathological staging of renal cell carcinoma: a review of 300 consecutive cases with emphasis on retrograde venous invasion. Histopathology. 2018;73(4):681\u201391.","journal-title":"Histopathology"},{"issue":"3","key":"5660_CR17","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1097\/01.ju.0000045706.35470.1e","volume":"169","author":"A Zisman","year":"2003","unstructured":"Zisman A, Wieder JA, Pantuck AJ, Chao DH, Dorey F, Said JW, et al. Renal cell carcinoma with tumor thrombus extension: biology, role of nephrectomy and response to immunotherapy. J Urol. 2003;169(3):909\u201316.","journal-title":"J Urol"},{"issue":"7","key":"5660_CR18","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1016\/j.urolonc.2011.12.006","volume":"31","author":"AC Reese","year":"2013","unstructured":"Reese AC, Whitson JM, Meng MV. Natural history of untreated renal cell carcinoma with venous tumor thrombus. Urol Oncol. 2013;31(7):1305\u20139.","journal-title":"Urol Oncol"},{"key":"5660_CR19","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.urology.2018.02.019","volume":"115","author":"R Hutchinson","year":"2018","unstructured":"Hutchinson R, Rew C, Chen G, Woldu S, Krabbe LM, Meissner M, et al. The Adverse Survival Implications of Bland Thrombus in Renal Cell Carcinoma With Venous Tumor Thrombus. Urology. 2018;115:119\u201324.","journal-title":"Urology"},{"issue":"4","key":"5660_CR20","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1007\/s00261-016-0962-x","volume":"42","author":"MS Davenport","year":"2017","unstructured":"Davenport MS, Hu EM, Smith AD, Chandarana H, Hafez K, Palapattu GS, et al. Reporting standards for the imaging-based diagnosis of renal masses on CT and MRI: a national survey of academic abdominal radiologists and urologists. Abdom Radiol (NY). 2017;42(4):1229\u201340.","journal-title":"Abdom Radiol (NY)"},{"issue":"2","key":"5660_CR21","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.juro.2013.02.033","volume":"190","author":"EJ Abel","year":"2013","unstructured":"Abel EJ, Wood CG, Eickstaedt N, Fang JE, Kenney P, Bagrodia A, et al. Preoperative pulmonary embolism does not predict poor postoperative outcomes in patients with renal cell carcinoma and venous thrombus. J Urol. 2013;190(2):452\u20137.","journal-title":"J Urol"},{"issue":"1","key":"5660_CR22","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1111\/j.1464-410X.2004.04897.x","volume":"94","author":"ML Blute","year":"2004","unstructured":"Blute ML, Leibovich BC, Lohse CM, Cheville JC, Zincke H. The Mayo Clinic experience with surgical management, complications and outcome for patients with renal cell carcinoma and venous tumour thrombus. BJU Int. 2004;94(1):33\u201341.","journal-title":"BJU Int"},{"issue":"7","key":"5660_CR23","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1111\/j.1464-410X.2012.11174.x","volume":"110","author":"SM Lawindy","year":"2012","unstructured":"Lawindy SM, Kurian T, Kim T, Mangar D, Armstrong PA, Alsina AE, et al. Important surgical considerations in the management of renal cell carcinoma (RCC) with inferior vena cava (IVC) tumour thrombus. BJU Int. 2012;110(7):926\u201339.","journal-title":"BJU Int"},{"issue":"5 Pt B","key":"5660_CR24","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1111\/j.1464-410X.2007.06826.x","volume":"99","author":"SA Boorjian","year":"2007","unstructured":"Boorjian SA, Sengupta S, Blute ML. Renal cell carcinoma: vena caval involvement. BJU Int. 2007;99(5 Pt B):1239\u201344.","journal-title":"BJU Int"},{"issue":"1","key":"5660_CR25","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1097\/01.rct.0000146113.56194.6d","volume":"29","author":"PJ Hallscheidt","year":"2005","unstructured":"Hallscheidt PJ, Fink C, Haferkamp A, Bock M, Luburic A, Zuna I, et al. Preoperative staging of renal cell carcinoma with inferior vena cava thrombus using multidetector CT and MRI: prospective study with histopathological correlation. J Comput Assist Tomogr. 2005;29(1):64\u20138.","journal-title":"J Comput Assist Tomogr"},{"issue":"2","key":"5660_CR26","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.juro.2007.09.042","volume":"179","author":"L Zini","year":"2008","unstructured":"Zini L, Destrieux-Garnier L, Leroy X, Villers A, Haulon S, Lemaitre L, et al. Renal vein ostium wall invasion of renal cell carcinoma with an inferior vena cava tumor thrombus: prediction by renal and vena caval vein diameters and prognostic significance. J Urol. 2008;179(2):450\u20134; discussion 4.","journal-title":"J Urol"},{"issue":"7","key":"5660_CR27","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.crad.2023.02.022","volume":"78","author":"RK Smith","year":"2023","unstructured":"Smith RK, Navaratnam A, Vivian P. Systematic review and meta-analysis of preoperative imaging prediction of renal cell carcinoma tumour thrombus inferior vena cava wall invasion. Clin Radiol. 2023;78(7):540\u20137.","journal-title":"Clin Radiol"},{"issue":"3","key":"5660_CR28","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1016\/S0022-5347(05)65280-9","volume":"167","author":"SA Aslam Sohaib","year":"2002","unstructured":"Aslam Sohaib SA, Teh J, Nargund VH, Lumley JS, Hendry WF, Reznek RH. Assessment of tumor invasion of the vena caval wall in renal cell carcinoma cases by magnetic resonance imaging. J Urol. 2002;167(3):1271\u20135.","journal-title":"J Urol"},{"issue":"1","key":"5660_CR29","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s40644-018-0150-z","volume":"18","author":"LC Adams","year":"2018","unstructured":"Adams LC, Ralla B, Bender YY, Bressem K, Hamm B, Busch J, et al. Renal cell carcinoma with venous extension: prediction of inferior vena cava wall invasion by MRI. Cancer Imaging. 2018;18(1):17.","journal-title":"Cancer Imaging"},{"issue":"3","key":"5660_CR30","doi-asserted-by":"publisher","first-page":"562","DOI":"10.2214\/AJR.18.20209","volume":"212","author":"A Alayed","year":"2019","unstructured":"Alayed A, Krishna S, Breau RH, Currin S, Flood TA, Narayanasamy S, et al. Diagnostic Accuracy of MRI for Detecting Inferior Vena Cava Wall Invasion in Renal Cell Carcinoma Tumor Thrombus Using Quantitative and Subjective Analysis. AJR Am J Roentgenol. 2019;212(3):562\u20139.","journal-title":"AJR Am J Roentgenol"},{"key":"5660_CR31","doi-asserted-by":"crossref","unstructured":"Reznek RH. CT\/MRI in staging renal cell carcinoma. Cancer Imaging. 2004;4 Spec No A(Spec No A):S25-32.","DOI":"10.1102\/1470-7330.2004.0012"},{"issue":"5","key":"5660_CR32","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1148\/rg.2021200202","volume":"41","author":"AM Abou Elkassem","year":"2021","unstructured":"Abou Elkassem AM, Lo SS, Gunn AJ, Shuch BM, Dewitt-Foy ME, Abouassaly R, et al. Role of Imaging in Renal Cell Carcinoma: A Multidisciplinary Perspective. Radiographics. 2021;41(5):1387\u2013407.","journal-title":"Radiographics"},{"issue":"10","key":"5660_CR33","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.1002\/cncr.22629","volume":"109","author":"V Margulis","year":"2007","unstructured":"Margulis V, S\u00e1nchez-Ortiz RF, Tamboli P, Cohen DD, Swanson DA, Wood CG. Renal cell carcinoma clinically involving adjacent organs: experience with aggressive surgical management. Cancer. 2007;109(10):2025\u201330.","journal-title":"Cancer"},{"issue":"5","key":"5660_CR34","doi-asserted-by":"publisher","first-page":"766","DOI":"10.21037\/tau.2018.07.19","volume":"7","author":"A Tadayoni","year":"2018","unstructured":"Tadayoni A, Paschall AK, Malayeri AA. Assessing lymph node status in patients with kidney cancer. Transl Androl Urol. 2018;7(5):766\u201373.","journal-title":"Transl Androl Urol"},{"issue":"2 Pt 1","key":"5660_CR35","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/S0022-5347(17)39422-3","volume":"144","author":"UE Studer","year":"1990","unstructured":"Studer UE, Scherz S, Scheidegger J, Kraft R, Sonntag R, Ackermann D, et al. Enlargement of regional lymph nodes in renal cell carcinoma is often not due to metastases. J Urol. 1990;144(2 Pt 1):243\u20135.","journal-title":"J Urol"},{"key":"5660_CR36","doi-asserted-by":"publisher","first-page":"112239","DOI":"10.1016\/j.ejrad.2025.112239","volume":"190","author":"C He","year":"2025","unstructured":"He C, Yuan E, Ye L, Xu H, Wu Q, Yao J, et al. Node-RADS 1.0 for lymph node involvement detection in renal cell carcinoma: A study on 2D and 3D CT imaging. Eur J Radiol. 2025;190:112239.","journal-title":"Eur J Radiol"},{"issue":"5","key":"5660_CR37","doi-asserted-by":"publisher","first-page":"814","DOI":"10.21037\/tau.2018.08.04","volume":"7","author":"I Caglic","year":"2018","unstructured":"Caglic I, Barrett T. Diffusion-weighted imaging (DWI) in lymph node staging for prostate cancer. Transl Androl Urol. 2018;7(5):814\u201323.","journal-title":"Transl Androl Urol"},{"issue":"5","key":"5660_CR38","doi-asserted-by":"publisher","first-page":"1806","DOI":"10.1097\/01.ju.0000120241.50061.e4","volume":"171","author":"DE Kang","year":"2004","unstructured":"Kang DE, White RL, Jr., Zuger JH, Sasser HC, Teigland CM. Clinical use of fluorodeoxyglucose F 18 positron emission tomography for detection of renal cell carcinoma. J Urol. 2004;171(5):1806\u20139.","journal-title":"J Urol"},{"issue":"21","key":"5660_CR39","doi-asserted-by":"publisher","first-page":"3995","DOI":"10.1200\/JCO.2003.04.073","volume":"21","author":"NS Majhail","year":"2003","unstructured":"Majhail NS, Urbain JL, Albani JM, Kanvinde MH, Rice TW, Novick AC, et al. F-18 fluorodeoxyglucose positron emission tomography in the evaluation of distant metastases from renal cell carcinoma. Journal of clinical oncology: official journal of the American Society of Clinical Oncology. 2003;21(21):3995\u20134000.","journal-title":"Journal of clinical oncology: official journal of the American Society of Clinical Oncology"},{"issue":"1","key":"5660_CR40","doi-asserted-by":"publisher","first-page":"56","DOI":"10.5414\/CNP57056","volume":"57","author":"A Safaei","year":"2002","unstructured":"Safaei A, Figlin R, Hoh CK, Silverman DH, Seltzer M, Phelps ME, et al. The usefulness of F-18 deoxyglucose whole-body positron emission tomography (PET) for re-staging of renal cell cancer. Clin Nephrol. 2002;57(1):56\u201362.","journal-title":"Clin Nephrol"},{"issue":"2","key":"5660_CR41","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.eururo.2015.08.053","volume":"69","author":"M Adibi","year":"2016","unstructured":"Adibi M, Kenney PA, Thomas AZ, Borregales LD, Nogueras-Gonz\u00e1lez GM, Wang X, et al. Prediction of Pulmonary Metastasis in Renal Cell Carcinoma Patients with Indeterminate Pulmonary Nodules. Eur Urol. 2016;69(2):352\u201360.","journal-title":"Eur Urol"},{"issue":"3","key":"5660_CR42","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1016\/j.juro.2014.09.020","volume":"193","author":"R Mano","year":"2015","unstructured":"Mano R, Vertosick E, Sankin AI, Chevinsky MS, Larish Y, Jakubowski CD, et al. Subcentimeter pulmonary nodules are not associated with disease progression in patients with renal cell carcinoma. J Urol. 2015;193(3):776\u201382.","journal-title":"J Urol"},{"issue":"1","key":"5660_CR43","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1097\/RCT.0b013e3181638144","volume":"33","author":"DC Jung","year":"2009","unstructured":"Jung DC, Choi HJ, Kim HY, Lee KH. Pulmonary metastasis from renal cell carcinoma: characterization using contrast-enhanced CT attenuation value measurements. J Comput Assist Tomogr. 2009;33(1):54\u20137.","journal-title":"J Comput Assist Tomogr"},{"issue":"2","key":"5660_CR44","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1148\/radiol.12120110","volume":"266","author":"YA Choi","year":"2013","unstructured":"Choi YA, Kim CK, Park BK, Kim B. Evaluation of adrenal metastases from renal cell carcinoma and hepatocellular carcinoma: use of delayed contrast-enhanced CT. Radiology. 2013;266(2):514\u201320.","journal-title":"Radiology"},{"issue":"2","key":"5660_CR45","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1177\/0284185115572207","volume":"57","author":"B Moosavi","year":"2016","unstructured":"Moosavi B, Shabana WM, El-Khodary M, van der Pol CB, Flood TA, McInnes MD, et al. Intracellular lipid in clear cell renal cell carcinoma tumor thrombus and metastases detected by chemical shift (in and opposed phase) MRI: radiologic-pathologic correlation. Acta Radiol. 2016;57(2):241\u20138.","journal-title":"Acta Radiol"},{"issue":"5","key":"5660_CR46","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.2214\/AJR.07.2799","volume":"190","author":"JH Song","year":"2008","unstructured":"Song JH, Chaudhry FS, Mayo-Smith WW. The incidental adrenal mass on CT: prevalence of adrenal disease in 1,049 consecutive adrenal masses in patients with no known malignancy. AJR Am J Roentgenol. 2008;190(5):1163\u20138.","journal-title":"AJR Am J Roentgenol"},{"key":"5660_CR47","doi-asserted-by":"crossref","unstructured":"Chen SC, Kuo PL. Bone Metastasis from Renal Cell Carcinoma. Int J Mol Sci. 2016;17(6).","DOI":"10.3390\/ijms17060987"},{"issue":"5","key":"5660_CR48","doi-asserted-by":"publisher","first-page":"538","DOI":"10.21873\/cdp.10252","volume":"3","author":"E Gambale","year":"2023","unstructured":"Gambale E, Palmieri VE, Rossi V, Francini E, Bonato A, Salfi A, et al. Bone Metastases in Renal Cell Carcinoma: Impact of Immunotherapy on Survival. Cancer Diagn Progn. 2023;3(5):538\u201342.","journal-title":"Cancer Diagn Progn"},{"issue":"8","key":"5660_CR49","doi-asserted-by":"publisher","first-page":"202","DOI":"10.4329\/wjr.v7.i8.202","volume":"7","author":"GJ O\u2019Sullivan","year":"2015","unstructured":"O\u2019Sullivan GJ, Carty FL, Cronin CG. Imaging of bone metastasis: An update. World J Radiol. 2015;7(8):202\u201311.","journal-title":"World J Radiol"},{"issue":"10","key":"5660_CR50","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.1093\/annonc\/mdv289","volume":"26","author":"EL Gerety","year":"2015","unstructured":"Gerety EL, Lawrence EM, Wason J, Yan H, Hilborne S, Buscombe J, et al. Prospective study evaluating the relative sensitivity of 18F-NaF PET\/CT for detecting skeletal metastases from renal cell carcinoma in comparison to multidetector CT and 99mTc-MDP bone scintigraphy, using an adaptive trial design. Annals of oncology: official journal of the European Society for Medical Oncology. 2015;26(10):2113\u20138.","journal-title":"Annals of oncology: official journal of the European Society for Medical Oncology"},{"issue":"3","key":"5660_CR51","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1102\/1470-7330.2012.0042","volume":"12","author":"HY Wang","year":"2012","unstructured":"Wang HY, Ding HJ, Chen JH, Chao CH, Lu YY, Lin WY, et al. Meta-analysis of the diagnostic performance of [18F]FDG-PET and PET\/CT in renal cell carcinoma. Cancer Imaging. 2012;12(3):464\u201374.","journal-title":"Cancer Imaging"},{"issue":"2","key":"5660_CR52","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1097\/MNM.0000000000000618","volume":"38","author":"H Ma","year":"2017","unstructured":"Ma H, Shen G, Liu B, Yang Y, Ren P, Kuang A. Diagnostic performance of 18F-FDG PET or PET\/CT in restaging renal cell carcinoma: a systematic review and meta-analysis. Nucl Med Commun. 2017;38(2):156\u201363.","journal-title":"Nucl Med Commun"},{"issue":"1","key":"5660_CR53","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1038\/s41598-021-04541-9","volume":"12","author":"AH Zhu","year":"2022","unstructured":"Zhu AH, Hou XY, Tian S, Zhang WF. Diagnostic value of (18)F-FDG PET\/CT versus contrast-enhanced MRI for venous tumour thrombus and venous bland thrombus in renal cell carcinoma. Sci Rep. 2022;12(1):587.","journal-title":"Sci Rep"},{"issue":"7","key":"5660_CR54","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.2967\/jnumed.124.267417","volume":"65","author":"MS Sadaghiani","year":"2024","unstructured":"Sadaghiani MS, Baskaran S, Gorin MA, Rowe SP, Provost JC, Teslenko I, et al. Utility of PSMA PET\/CT in Staging and Restaging of Renal Cell Carcinoma: A Systematic Review and Metaanalysis. J Nucl Med. 2024;65(7):1007\u201312.","journal-title":"J Nucl Med"},{"issue":"9","key":"5660_CR55","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1007\/s00259-019-04358-9","volume":"46","author":"SR Verhoeff","year":"2019","unstructured":"Verhoeff SR, van Es SC, Boon E, van Helden E, Angus L, Elias SG, et al. Lesion detection by [(89)Zr]Zr-DFO-girentuximab and [(18)F]FDG-PET\/CT in patients with newly diagnosed metastatic renal cell carcinoma. Eur J Nucl Med Mol Imaging. 2019;46(9):1931\u20139.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"980","key":"5660_CR56","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1259\/bjr\/52773262","volume":"82","author":"SA Sohaib","year":"2009","unstructured":"Sohaib SA, Cook G, Allen SD, Hughes M, Eisen T, Gore M. Comparison of whole-body MRI and bone scintigraphy in the detection of bone metastases in renal cancer. Br J Radiol. 2009;82(980):632\u20139.","journal-title":"Br J Radiol"},{"issue":"5","key":"5660_CR57","doi-asserted-by":"publisher","first-page":"581","DOI":"10.3109\/02841851003724846","volume":"51","author":"I Platzek","year":"2010","unstructured":"Platzek I, Zastrow S, Deppe PE, Grimm MO, Wirth M, Laniado M, et al. Whole-body MRI in follow-up of patients with renal cell carcinoma. Acta Radiol. 2010;51(5):581\u20139.","journal-title":"Acta Radiol"},{"issue":"1","key":"5660_CR58","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1148\/radiology.205.1.9314970","volume":"205","author":"EK Outwater","year":"1997","unstructured":"Outwater EK, Bhatia M, Siegelman ES, Burke MA, Mitchell DG. Lipid in renal clear cell carcinoma: detection on opposed-phase gradient-echo MR images. Radiology. 1997;205(1):103\u20137.","journal-title":"Radiology"},{"issue":"8","key":"5660_CR59","doi-asserted-by":"publisher","first-page":"5120","DOI":"10.1007\/s00330-023-10397-6","volume":"34","author":"D Leithner","year":"2024","unstructured":"Leithner D, Sala E, Neri E, Schlemmer H-P, D\u2019Anastasi M, Weber M, et al. Perceptions of radiologists on structured reporting for cancer imaging\u2014a survey by the European Society of Oncologic Imaging (ESOI). European radiology. 2024;34(8):5120\u201330.","journal-title":"European radiology"},{"issue":"1","key":"5660_CR60","doi-asserted-by":"publisher","first-page":"2","DOI":"10.2214\/AJR.15.15895","volume":"207","author":"DM Panicek","year":"2016","unstructured":"Panicek DM, Hricak H. How Sure Are You, Doctor? A Standardized Lexicon to Describe the Radiologist\u2019s Level of Certainty. AJR Am J Roentgenol. 2016;207(1):2\u20133.","journal-title":"AJR Am J Roentgenol"}],"container-title":["Abdominal Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00261-026-05660-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00261-026-05660-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00261-026-05660-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T09:02:25Z","timestamp":1783328545000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00261-026-05660-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,6]]},"references-count":60,"alternative-id":["5660"],"URL":"https:\/\/doi.org\/10.1007\/s00261-026-05660-5","relation":{},"ISSN":["2366-0058"],"issn-type":[{"value":"2366-0058","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,6]]},"assertion":[{"value":"29 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}